Join Clinical Trials for Healthy Volunteers in South Australia

All Categories Healthy Participants » Australia » South Australia

First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Condition: Hepatitis C, Chronic
Interventions: Drug: ALS-002158; Drug: Placebo
Sponsors: Alios Biopharma Inc.; Alios Biopharma Inc.; Vertex Pharmaceuticals Incorporated
Recruiting - verified March 2012
Evaluation of Transdermal Nicotine Replacement Therapy (NRT) Activity Through Metabolic Induction

Conditions: Smoking; Addiction
Intervention: Drug: Nicabate 21mg Transdermal Nicotine Replacement Therapy (NRT)Patch
Sponsors: The Queen Elizabeth Hospital; The Queen Elizabeth Hospital; Basil Hetzel Institute for Translational Research; University of Adelaide; University of South Australia; Clinical Practice Unit; Therapeutics Research Centre
Recruiting - verified September 2011
Safety and Immunogenicity of Novartis Meningococcal B Vaccine Formulated With OMV Manufactured at Two Different Sites, in Healthy Adolescents Aged 11-17 Years

Conditions: Meningococcal Disease; Meningococcal Meningitis
Intervention: Biological: Serogroup B meningococcal vaccine
Sponsors: Novartis; Novartis; Novartis Vaccines
Completed - verified January 2012
Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers

Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: GSK2018682; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified February 2012
Study of Ketamine Administered Intravenously and by Sublingual Wafer

Condition: Pain
Intervention:
Sponsors: IX Biopharma Pte. Ltd.; IX Biopharma Pte. Ltd.
Recruiting - verified June 2011
GSK2018682 FTIH in Healthy Volunteers

Condition: Multiple Sclerosis
Interventions: Drug: GSK2018682; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified January 2012
Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children

Condition: Influenza Infection
Intervention: Biological: GSK Biologicals' investigational vaccine GSK1562902A
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified January 2012
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Conditions: Ulcerative Colitis; Crohn's Disease
Interventions: Drug: AMG 181; Other: Placebo for AMG 181
Sponsors: Amgen; Amgen
Recruiting - verified May 2012
A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects

Condition: Infections, Bacterial
Interventions: Drug: GSK2251052; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified February 2012
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects

Condition: Crohn's Disease
Intervention: Drug: AMG 139
Sponsors: Amgen; Amgen
Recruiting - verified May 2012
Ross River Virus (RRV) Vaccine Study

Condition: Prophylaxis of Ross River Virus Infection
Intervention: Biological: Ross River Virus Vaccine
Sponsors: Baxter Healthcare Corporation; Baxter Healthcare Corporation
Active, not recruiting - verified October 2011
Metabolic Phenotyping of Individuals Born Following Assisted Reproduction Techniques

Conditions: Metabolic Syndrome; Diabetes
Intervention: Dietary Supplement: high fat overfeeding
Sponsors: University of Adelaide; University of Adelaide
Recruiting - verified October 2010
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

Condition: Ulcerative Colitis
Intervention: Drug: Amg 181
Sponsors: Amgen; Amgen
Recruiting - verified May 2012
An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults

Conditions: Bacterial Infections; Staphylococcal Vaccines; Immunotherapy, Active; Staphylococcal Skin Infections; Staphylococcal Infections
Interventions: Biological: SA3Ag vaccine; Procedure: Blood draw; Procedure: Colonization swab samples; Biological: SA3Ag followed by Placebo; Procedure: Blood draw; Procedure: Colonization swab samples; Biological: Placebo; Procedure: Blood draw; Procedure: Colonization swab samples; Biological: SA3Ag with no booster in stage 2; Procedure: Blood draw; Procedure: Colonization swab samples; Procedure: Placebo with no booster in stage 2; Procedure: Blood draw; Procedure: Colonization swab samples
Sponsors: Pfizer; Pfizer
Completed - verified August 2011
EU/LA Pearl Index Study - Transdermal Contraceptive Patch

Condition: Contraception
Intervention: Drug: Ethinylestradiol/Gestodene (BAY86-5016)
Sponsors: Bayer; Bayer
Completed - verified October 2011
Safety Study of CSL Limited's Influenza Virus Vaccine in the Paediatric Population Aged >= 6 Months to < 18 Years

Condition: Influenza
Interventions: Biological: CSL Limited Influenza Virus Vaccine; Biological: CSL Limited Influenza Virus Vaccine; Biological: CSL Limited Influenza Virus Vaccine
Sponsors: CSL Limited; CSL Limited
Completed - verified August 2011
A Study Evaluating Safety And Immunogenicity Of Meningococcal B Rlp2086 Vaccine In Adolescents

Condition: Meningitis, Meningococcal
Interventions: Biological: meningococcal B rLP2086 vaccine.; Biological: meningococcal B rLP2086 vaccine.; Biological: meningococcal B rLP2086 vaccine.; Other: normal saline (placebo)
Sponsors: Pfizer; Pfizer
Active, not recruiting - verified April 2012
Osteonecrosis of the Hip and Bisphosphonate Treatment

Condition: Osteonecrosis
Interventions: Drug: Zoledronic Acid; Drug: Placebo
Sponsors: University of Sydney; University of Sydney; Novartis
Recruiting - verified February 2011
Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers

Conditions: Alzheimer Disease; Amyloid Beta-Protein
Intervention: Drug: Florbetaben (BAY94-9172)
Sponsors: Bayer; Bayer
Completed - verified December 2011
International Study to Predict Optimised Treatment - in Depression

Condition: Major Depressive Disorder
Interventions: Drug: Escitalopram; Drug: Sertraline; Drug: Venlafaxine XR
Sponsors: BRC Operations Pty. Ltd.; BRC Operations Pty. Ltd.
Recruiting - verified March 2012
A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to < 24 Month-Old Children and in 2 Month Old Infants

Conditions: Respiratory Syncytial Virus (RSV); Parainfluenza Virus Type 3 (PIV3)
Interventions: Biological: MEDI-534; Biological: MEDI-534; Biological: MEDI-534; Biological: MEDI-534; Biological: MEDI-534; Biological: Placebo
Sponsors: MedImmune LLC; MedImmune LLC
Active, not recruiting - verified May 2012
A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Volunteers Who Receive Long-term Prophylaxis Against Pandemic Influenza: PIPET B

Condition: Pandemic Influenza
Intervention:
Sponsors: Kirby Institute; Kirby Institute; National Health and Medical Research Council, Australia
Withdrawn - verified April 2012
A Prospective Study to Examine the Effectiveness and Safety of Antivirals in Volunteers Who Receive Short-term Prophylaxis Against Pandemic Influenza

Condition: Pandemic Influenza
Intervention:
Sponsors: Kirby Institute; Kirby Institute; National Health and Medical Research Council, Australia
Withdrawn - verified April 2012
A Study of the Efficacy, Safety and Tolerability Profile of CSL Limited's Influenza Virus Vaccine (CSL's IVV) Administered Intramuscularly in Healthy Adults

Condition: Influenza
Interventions: Biological: CSL Limited Influenza Vaccine; Biological: Placebo
Sponsors: CSL Limited; CSL Limited
Completed - verified August 2011
To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects

Conditions: Healthy Subjects; Infections, Bacterial
Interventions: Drug: GSK945237; Drug: Sugar Pill
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified October 2011
Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients

Condition: Locally Recurrent and Metastatic Breast Cancer
Interventions: Drug: AMG 386 Placebo; Drug: AMG 386; Drug: Bevacizumab; Drug: AMG 386; Drug: AMG 386; Drug: Paclitaxel
Sponsors: Amgen; Amgen
Active, not recruiting - verified September 2011
Effects of Sitagliptin on Gastric Emptying in Healthy Subjects

Conditions: Gastroparesis; Diabetes Mellitus
Interventions: Drug: Sitagliptin; Drug: Sitagliptin
Sponsors: Royal Adelaide Hospital; Royal Adelaide Hospital; Merck
Active, not recruiting - verified August 2011
A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subjects

Conditions: Healthy Subjects; Anaemia
Interventions: Drug: GSK626616, placebo, midazolam; Drug: omeprazole, caffeine, flurbiprofen, rosiglitazone
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified February 2011
Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

Conditions: Hepatic Impairment; Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: eltrombopag
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified April 2012
Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.

Conditions: Meningococcal Infection; Haemophilus Infection
Interventions: Biological: Haemophilus influenzae type b and meningococcal serogroup C (vaccine); Biological: Priorix™; Biological: Hiberix™; Biological: Meningitec™
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified September 2011
Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared

Conditions: Hepatitis B; Hepatitis A
Interventions: Biological: Twinrix™ Adult; Biological: Twinrix™ Junior
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified November 2011
Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18.

Conditions: Human Papillomavirus (HPV) Infection; Cervical Neoplasia
Intervention: Biological: HPV-16/18 L1/AS04
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified March 2012
Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18

Conditions: Human Papillomavirus (HPV) Infection; Cervical Neoplasia
Interventions: Biological: Cervarix™; Biological: Havrix™-based investigational formulation
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified February 2012